Analyst Ranking
Bottom 3%
#4772 out of 4875 analysts
Average Return
-17.68%
Win Rate
25%8 out of 32
Risk vs Reward
Poor
Good

Douglas Miehm's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Aurinia Pharmaceuticals IncAUPH
+59.81%$5.15$8.23
2022-11-04 -
2023-11-03
Buy
Aurinia Pharmaceuticals IncAUPH
+33.16%$5.85$7.79
2024-02-16 -
2025-02-14
Buy
Bausch & Lomb CorpBLCO
+29.12%$15.35$19.82
2022-07-26 -
2023-07-25
Buy
Aurinia Pharmaceuticals IncAUPH
+25.74%$6.72$8.45
2023-01-04 -
2024-01-03
Buy
Bausch & Lomb CorpBLCO
+23.74%$13.65$16.89
2022-11-03 -
2023-11-02
Buy

Douglas Miehm Analyst Color

Get additional color on Douglas Miehm's coverage of popular stocks

Douglas Miehm's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Bausch Health Companies IncBHC
19Hold$10.00+117.86%Maintains
9 days ago
Bausch & Lomb CorpBLCO
13Buy$17.00+50.84%Maintains
a month ago
Oncolytics Biotech IncONCY
1Buy$5.00+863.39%Maintains
2 months ago
Ligand Pharmaceuticals IncLGND
5Buy$143.00+36.87%Maintains
5 months ago
Aurinia Pharmaceuticals IncAUPH
8Buy$8.00N/AMaintains
a year ago
Crh Medical CorpCRHM
1HoldN/AN/ADowngrades
4 years ago
Novadaq Technologies IncNVDQ1
1HoldN/AN/ADowngrades
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.